Navigation Links
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
Date:7/22/2014

trix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including oncology, diabetes and dermatology that have significant unmet medical need today. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer and Baxter. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement 
In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning future actions relating to the development of PEGPH20 such as additional approvals of clinical sites by IRBs and the possibility that PEGPH20 may be used to address pancreatic cancer) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are typically, but not always, identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including delays in the approval of clinical sites by IRBs, the possibility that the revised protocol may not address the apparent increased rate of thromboembolic events observed with the use of PEGPH20 in the trial or satisfy future regulatory requirements, the possibility of additional safety events, unexpected expenditures and costs, unexpected results
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
2. Halozyme Secures Additional $20 Million Term Loan
3. Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics
4. Halozyme Therapeutics Announces Executive Transitions
5. Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference
6. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
7. Halozyme to Host Third Quarter 2013 Financial Results Conference Call
8. SWOG Initiates Randomized Phase 2 Clinical Trial of Halozymes PEGPH20 in Combination with modified FOLFIRINOX for Advanced Pancreatic Cancer
9. Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013
10. Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
11. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  EP Global Communications, ... have recently contacted the Company about discussing EPGL,s ... early as Monday, August 3, 2015.  Novartis CEO ... saying that the coming electronic contact lens market ... over the next several years.  Novartis partnered with ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:7/30/2015)... THOUSAND OAKS, Calif. , July 30, 2015  Amgen ... Fred Hassan , partner and managing director of Warburg Pincus ... "We are pleased to welcome Fred Hassan and ... to the Amgen Board," said Robert A. Bradway , ... expertise and commitment to innovation will serve Amgen well." ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3
...  American HealthTech ( www.healthtech.net ), the Ultimate Connectivity ... Wound Management to Quality Assurance.  In a single ... Braden assessment wizard to enhance quality care planning ... added to Outcomes Reporting for providers wanting to ...
... Feb. 23, 2012 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... to present at the Citi 2012 Global Health Care Conference ... (10:30 a.m. Pacific Time) at the Waldorf=Astoria in New York ... scheduled to provide a corporate overview. A live ...
Cached Medicine Technology:American HealthTech Announces Comprehensive Wound Management 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 3
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... in Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by ... predictive health analytics , Jvion continues to disrupt the predictive analytic and ... that targets patient and population level illness to drive prevention and better health ...
(Date:7/31/2015)... Tenn. (PRWEB) , ... July 31, 2015 , ... The ... Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight ... focused on cancer research between Methodist Healthcare, The West Clinic and The University of ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy the summer ... to cook the next meal, making July the most appropriate to be National Hot ... and recipes. , Make the next cookout different than the ones in the past. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and blogs ... social media profiles to better connect with the public. The agency website at ... share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... the late 1990s, deep brain stimulation (DBS) has proven ... Parkinson,s disease, a cruel neurological disorder that can cause ... and rigidity, among other symptoms. The ... be adequately controlled with medications. A neurosurgeon uses magnetic ...
... sexual function that leave them feeling guilty and a ... Congress of the European Society for Medical Oncology (ESMO) ... and fertility concerns are often not adequately addressed by ... Centre in Adelaide said that fertility concerns among cancer ...
... Overhage, M.D., Ph.D., a national leader in the development ... exchange, has been elected to the prestigious Institute of ... Dr. Overhage is at the forefront of policy, standards, ... of medical data to improve patient care delivery and ...
... the subject of many studies since its discovery in ... of XMRV,s role in human disease. In three recent ... Journal of Infectious Diseases , now available online, ... prostate cancer but not other links involving chronic fatigue ...
... TUESDAY, Oct. 12 (HealthDay News) -- The so-called racial gap ... with black and Hispanic women less likely to get ... known is what the issue is -- is it race ... a medical oncologist at Dana Farber Cancer Institute in Boston, ...
... 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will ... which will be held Dec. 8-12 in the Henry ... M.D., Ph.D., is the recipient of the 2010 AACR ... Susan G. Komen for the Cure. Alan Ashworth, Ph.D., ...
Cached Medicine News:Health News:Researchers reach consensus on use of deep brain stimulation to treat Parkinson's 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 3Health News:J. Marc Overhage elected to Institute of Medicine 2Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3Health News:Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care 2Health News:Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care 3Health News:AACR to honor leading researchers at breast cancer symposium 2
... unique fiberoptic laryngoscope blade that can give ... needed during difficult intubations. The articulating tip ... to be raised by squeezing a lever ... produces a more complete exposure of the ...
... laryngoscope handles can be used with Portex® ... sturdy chrome blades with long-lasting bronze fiber-optic ... for continuous routine use., ,The laryngoscope ... of sizes, from infant to large adult, ...
... handles can be used with Portex® reusable ... chrome blades with long-lasting bronze fiber-optic bundles ... continuous routine use., ,The laryngoscope blades ... sizes, from infant to large adult, and ...
... an innovative intubation system. Providing an unobstructed ... is ideal for many types of intubations., ... embedded within the patented Glidescope blade. Clear ... displayed on a monitor screen. An LED ...
Medicine Products: